Pfizer Blood Pressure Drug Recalled Over Cancer-Causing Chemical

NEW YORK CITY — Drugmaker Pfizer has issued a voluntary recall for several blood pressure drugs after finding elevated levels of a possible cancer-causing chemical, according to a statement from the New York City-based company.

The recall affects several lots of Accuretic as well as two authorized generic versions of the drug, quinapril and hydrochlorothiazide. According to the company, the tainted lots contain nitrosamine above the acceptable daily intake level.

Nitrosamines are common in water and foods, including cured and grilled meats, dairy products, and vegetables, according to the Food and Drug Administration. While everyone is exposed to some level of nitrosamines, these impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

The affected drugs are prescribed for the treatment of hypertension to reduce the risk of cardiovascular events, primarily strokes, and myocardial infarctions, according to Pfizer.

The tainted lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from November 2019 to March 2022, Pfizer said.

Check here for a list of the lot numbers of the drugs being recalled.

Pfizer recommends that anyone taking these drugs consult their health care provider or pharmacy to determine if they have the affected product. Those with the affected product should call 888-843-0247 for instructions on how to return their product and obtain reimbursement.